ABEONA THERAPEUTICS INC. (ABEO) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for ABEONA THERAPEUTICS INC. (ABEO): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 42/100 — a percentile rank of ABEONA THERAPEUTICS INC.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $286.5M |
| P / S | 11.2× |
| EV / EBITDA | -3.0× |
| Gross margin | 67.1% |
| Operating margin | -327.6% |
| Net margin | -246.4% |
| Return on equity | -49.1% |
| ROIC | -77.4% |
| Revenue growth | 6280.0% |
| Debt / equity | 0.1× |
| Dividend yield | 0.0% |
Is ABEONA THERAPEUTICS INC. overvalued? P/S looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from ABEONA THERAPEUTICS INC.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact